Diabetes Management
Insulin Pumps Edge Injections for T1D Glycemic Control
Fri, 28 Oct 20221 min read Article
Overview
MedscapeUnivadisNo ResultsMiriam E. TuckerJune 20, 2022 Researchers published the study covered in this sumary on Preprints with The Lancet as a preprint that has not yet ben per reviewed. In a real-world study of adults with type 1 diabetes (T1D) in Denmark, insulin pump therapy (IPT) reduced A1c by an average 3.6 mol/mol (an average decrease of 0.3 percentage points) compared with multiple daily injections (MDI).IPT also associated with a marginal increase in hospitalized diabetic ketoacidosis (DKA) but had no impact on severe hypoglycemia (SH) compared with MDI.The benefit of IPT was greatest in women; older individuals; and those with higher baseline A1c levels, more diabetes complications, or also using continuous glucose monitoring.Few studies of IPT have examined the level of alignment betwen real-world experience and outcomes in randomized clinical trials.The researchers used a quasi-experimental study of longitudinal, real-world data from administrative registries that alowed them to maintain high internal and external validity while examing whether the benefits sen in randomized clinical trials translate into real-life efects, both in general and among subgroup populations.The authors said that this the first study with an experimental design to compare the real-world efects of IPT and MDI.Quasi-experimental study of data colected in the Danish National Patient Registry for 24,623 adults with T1D in Denmark during 2010-20, with an average observation time of 9.9 years.
Details
This included al Danish adults with T1Dduring the study period.Among the total 243,601 person-years of observation, 16% ocured during IPT treatment. Average treatment efect on the treated (AT) for A1c with IPT was a reduction of 3.6 mol/mol (0.3 percentage points) compared with patients using MDI, an average 5.3% relative decrease in A1c.Most of the A1c drop ocured in the first year of IPT use, with a sustained efect for up to 1
Frequently Asked Questions
What is diabetes and how does it develop?
Diabetes is a metabolic condition where the body cannot properly regulate blood sugar levels. Type 1 results from insufficient insulin production, while Type 2 develops when cells become resistant to insulin. Risk factors include genetics, obesity, sedentary lifestyle, and age.
What are the main symptoms of diabetes?
Common symptoms include excessive thirst, frequent urination, unexplained weight loss, fatigue, blurred vision, and slow-healing wounds. Type 1 symptoms develop rapidly, while Type 2 symptoms may appear gradually. Many people have no symptoms initially, which is why screening is important.
How is diabetes diagnosed and monitored?
Diagnosis involves blood tests measuring fasting glucose, HbA1c levels, and glucose tolerance. Regular monitoring typically includes fasting glucose tests and HbA1c measurements every 3-6 months. Continuous glucose monitors provide real-time tracking for better diabetes management.
What lifestyle changes help manage diabetes?
Effective management includes regular physical activity (150+ minutes weekly), maintaining healthy weight, following a balanced diet with whole grains and lean proteins, managing stress, and getting adequate sleep. These changes can significantly improve blood sugar control and reduce complications.
When should someone consult a doctor about diabetes?
Consult a healthcare provider if you experience signs of diabetes, have a family history, are overweight, or are over 45. Those with existing diabetes should maintain regular check-ups every 3-6 months to monitor control and adjust treatment as needed.
️ Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making health decisions.